Governments around the world are accelerating AI adoption in pharmaceuticals, with the U.S. launching a $500 billion Stargate Project in January this year to redesign mRNA-based cancer therapies ...

Ellison added, "You can make that mRNA vaccine, robotically and using AI in 48 hours. So imagine early cancer detection, the development of a vaccine for your particular cancer aimed at you and ...

Everest Medicines unveils breakthroughs in AI+mRNA platform, reinforces global leadership in next-gen mRNA innovation: Hong Kong Monday, July 7, 2025, 10:00 Hrs [IST] Everest Medi ...

"So imagine early cancer detection, the development of a cancer vaccine for your particular cancer aimed at you, and have had that vaccine available in 48 hours. This is the promise of AI and the ...

“It came as a surprise that our approach works so well,” Lu said. In preclinical (non-human) studies, the vaccine completely ...

Evaxion’s AI-Immunology™ platform allows for the design of precision cancer vaccines targeting non-conventional ERV tumor antigens shared across p ...

Generation of additional clinical data allows for a more comprehensive assessment of the full potential of EVX-01, while strengthening the already strong clinical data packageWill provide insights ...

Cancer vaccines have been a tantalizing idea for decades, but the vast complexity of the human immune system has posed significant challenges. ... Harnessing AI for personalized antigen selection.

What if preventing cancer was as easy as a text message? A recent study at Huntsman Cancer Institute found that 70% of Utah kids and teens had missed an opportunity to be immunized against HPV, and ...

Designed with Evaxion’s AI-Immunology™ platform, EVX-01 is a personalized cancer vaccine currently being evaluated as a treatment for advanced melanoma (skin cancer).